Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sanofi (SAN.FP)

Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sanofi 46, avenue de la Grande Armée Paris 75017 FRA

P: +33 153774000

Description:

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Key Statistics

Overview:

Market Capitalization, $K 116,184,827
Shares Outstanding, K 1,248,225
Annual Sales, $ 46,444 M
Annual Net Income, $ 5,400 M
Last Quarter Sales, $ 11,118 M
Last Quarter Net Income, $ 1,133 M
% of Institutional Shareholders 41.96%

Growth:

1-Year Return -6.75%
3-Year Return 6.86%
5-Year Return 25.55%
5-Year Revenue Growth 5.42%
5-Year Earnings Growth 4.62%
5-Year Dividend Growth 3.28%

Per-Share Information:

Most Recent Earnings 0.91 on 04/25/24
Latest Earnings Date N/A
Earnings Per Share ttm 3.61
EPS Growth vs. Prev Qtr 74.78%
EPS Growth vs. Prev Year -32.28%
Annual Dividend Rate, $ 3.56
Annual Dividend Yield 4.09%
Most Recent Dividend 3.760 on 05/13/24
Next Ex-Dividends Date 05/13/24
Dividend Payable Date 05/15/24
Dividend Payout Ratio 98.61%

SAN.FP Ratios

Ratio
Price/Earnings ttm 25.46
Price/Earnings forward 11.90
Price/Earnings to Growth 0.90
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 11.63%
Debt/Equity 0.22
Price/Sales 2.46
Price/Cash Flow 11.21
Price/Book 1.55
Book Value/Share 59.32
Interest Coverage 11.85
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar